Phase II study of capecitabine single-ag
Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma
โ
Lance C. Pagliaro; Cherie A. Perez; Shi-Ming Tu; Danai D. Daliani
๐
Article
๐
2006
๐
Elsevier Science
๐
English
โ 95 KB